Baird lowered the firm’s price target on Iqvia to $245 from $254 and keeps a Neutral rating on the shares. The firm said they squeaked out minor 1Q24 upside versus Street, though absolute growth of revenue, EBITDA , and EPS, remained sluggish, while the company talked down 2Q expectations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV: